Riley Antony A 内部人交易：近期 SEC Form 4 交易
过去 18 个月，Riley Antony A（CIK 1339375）在 1 家公司共报告 12 笔 SEC Form 4 内部人交易（最近一笔 2026-08-27）。
| 日期 | 公司 | 身份 | 类型 | 股数 | 市值 |
|---|---|---|---|---|---|
| 2026-08-27 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 42,600 | $0 |
| 2026-07-06 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 375 | $0 |
| 2026-07-06 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 134 | $2,857 |
| 2026-04-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 375 | $0 |
| 2026-04-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 134 | $3,331 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 9,680 | $254,874 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 375 | $0 |
| 2026-01-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 154 | $4,200 |
| 2025-10-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 375 | $0 |
| 2025-10-02 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 134 | $1,946 |
| 2025-07-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 买入 | 375 | $0 |
| 2025-07-03 | Forte Biosciences, Inc. (FBRX) | CHIEF FINANCIAL OFFICER | 卖出 | 134 | $1,667 |
来源：SEC Form 4 申报文件 · 截至 2026-08-27